Aduro Biotech Europe
2011
FOUNDED
M&A
STATUS
21-30
EMPLOYEES
M&A
LATEST DEAL TYPE
$64.6M
LATEST DEAL AMOUNT
Description
Provider of therapeutic services for cancer. The company specializes in the development of oncology antibodies for the treatment of cancer.
Website
Formerly Known As
BioNovion
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- Pivot Park, RX1101
- Molenweg 79
- 5349 AC OSS
- Netherlands
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Aduro Biotech Europe’s full profile, request a free trial.
Aduro Biotech Europe Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 30-Oct-2015 | $64.6M | 000.00 | Completed | Generating Revenue | |
| 1. Early Stage VC | Completed | Startup |
Aduro Biotech Europe Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Agri Food Health Innovation Centre | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Brabant Life Sciences Seed Fund | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Brabantse Ontwikkelings Maatschappij | Venture Capital | Minority | 000 0000 | 000000 0 |